Lucid Focus Group

Your content. Their perspective. Results within hours.

AI-powered expert panels — grounded in 20 years of pharmaceutical and health communication expertise — evaluate your healthcare content before it reaches your audience.

The content testing gap

Traditional content testing is slow, expensive, and hard to repeat

Small panels miss key audience segments

No way to run pre-launch healthcare content testing without significant cost and risk

Feedback arrives too late to change course

“Getting the science right is hard enough. Knowing how it actually lands? That’s the blind spot.”

What Lucid Focus Group delivers

Synthetic audience testing purpose-built for healthcare and scientific content.

Expert Panels

3–8 synthetic personas built with deep domain and audience expertise, not generic demographics. Each persona draws on real clinical, regulatory, and professional context.

Structured Evaluation

Rigorous AI content evaluation on criteria that matter for your content type — rated, justified, and cited.

Ranked Recommendations

Prioritised recommendations ranked by impact — ready to implement, not vague advice.

Scored and justified, not vague and subjective. Hours, not weeks. Fresh perspectives on every draft.

Five steps from brief to insights

01

Discovery

We understand your content, audience, goals, and ethical guardrails.

02

Persona Build

3–8 synthetic personas grounded in real audience psychology, domain expertise, and research.

03

Roundtable

Structured evaluation — personas rate, justify, and debate every criterion from their perspective.

04

Synthesis

Prioritised recommendations ranked by impact — with specific, implementable next steps.

05

Iterate

Submit your revised content for a fresh AI audience evaluation — see exactly what improved and what still needs work.

Content types we evaluate

Landing pagesPatient communicationEducational contentWhite papersEmail campaignsPitch decksPublic health campaignsGrant proposals

Proof of Concept

What the panel found before launch — and what would have gone unnoticed without it.

National Health Organisation

Cancer Screening & Early Detection Page

8 personas | Public health landing page

3.0/5

Overall: “Adequate

  • No personalised screening tool (6/8 requested)
  • Indigenous content structurally siloed
  • Emotional disconnect — informational but flat
  • Inclusivity scored lowest at 2.0/5

An email campaign that worked for one audience segment. The panel identified three more it was missing.

Medical Affairs Training Provider

Post-Webinar Recap Email Campaign

8 personas | Email + strategic review

3.3/5

Overall: “Functional

  • Serves "breaking in" audience; ignores "progressing"
  • Actionability weakest dimension (2.6/5)
  • Content-to-commerce transition unsignposted
  • Strategic review recommended 4-stream segmentation

Both evaluations completed in under 2 hours — synthetic audience testing that would take weeks with a traditional panel.

Data Privacy & Trust

Your content is confidential. Your data governance is non-negotiable. Here’s how we protect both.

No client content used for AI training

Each focus group runs in an isolated session. Your content is never carried across projects. Session data is archived securely for 30 days, then permanently deleted.

No system access required

We work from the content you provide. If you have audience insights to share, we can use them to enrich the evaluation — but we’ll never need access to your CRM, internal systems, or patient data.

Human-reviewed before delivery

Every evaluation is reviewed for quality before delivery, not auto-generated and handed over.

NDA and confidentiality available

Happy to sign mutual NDAs before any content is shared. Standard practice for pharmaceutical engagements.

Built by a pharmacist who’s spent 20 years navigating pharmaceutical compliance. Data governance isn’t an afterthought — it’s how we operate.

Built by Feisia Dam

Registered pharmacist with 20 years in pharmaceutical communications — including AstraZeneca and Pfizer. Lucid Focus Group brings the same rigour to content evaluation that regulated industries demand from their science.

Connect on LinkedIn →